COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804


Print ISSN:-2394-2746

Online ISSN:-2394-2754

CODEN : IJOGCS

Current Issue

Year 2020

Volume: 7 , Issue: 1

Article Access statistics

Viewed: 659

Emailed: 0

PDF Downloaded: 221

Indian Journal of Obstetrics and Gynecology Research


Evaluation of efficacy, safety and cost effectiveness of oral iron and injectable iron sucrose and ferric carboxy maltose in pregnant women in 2nd and 3rd trimester in anaemia


Full Text PDF Share on Facebook Share on Twitter


Author Details : Bharti Maheshwari, Varisha Mahtab, Smita Tyagi, Prachi Tyagi

Volume : 4, Issue : 1, Year : 2017

Article Page : 96-100


Suggest article by email


Abstract

Objective: To compare the efficacy safety and cost effective of oral iron and injectable iron sucrose and FCM in pregnancy in 2nd and 3rd trimester.
Methods: A prospective randomised control trial study in 300 women with HB 7-9gm% done in department of obstetrics on Gynae in Muzaffarnagar Medical College, Muzaffarnagar.
Result: Mean changes in Hb: oral iron 9.14gm%, inj.iron sucrose 10.54gm%, inj FCM 11.66gm%. The value of p is < 0.00001. The result is significant at p ≤0.05. Mean changes in PCV: oral iron 25.1%, inj iron sucrose 36.7%, inj FCM 37.46%. The value of p is <0.00001. The result is significant at p ≤ 0.05.Mean changes in MCV: oral iron 74.5Fl. The value of p is 0.172115. The result is not significant at p ≤ 0.05., inj iron sucrose 72.52.4Fl, inj FCM 80.4Fl. The value of p is < 0.00001. The result is significant at p ≤ 0.05.Mean changes in MCHC: oral iron 32.9%, inj iron sucrose 37.6%, inj FCM39.31%. The value of p is < 0.00001. The result is significant at p ≤ 0.05 Mean changes in serum feritin oral iron 28.95 µg/l, inj iron sucrose 29.25 µg/l, inj FCM 47.3µg/l. The value of p is < 0.00001. The result is significant at p ≤ 0.05.Mean changes in serum iron oral iron 36.27µg/dL, inj iron sucrose 38.1 µg/dL, inj FCM 73.8 µg/dL. The value of p is < 0.00001. The result is significant at p ≤ 0.05. Mean decrease in TIBC: oral iron 369µg/dL, inj iron sucrose 330µg/dL, inj FCM 324 µg/dL. The value of p is < 0.00001. The result is significant at p ≤ 0.05. Regarding efficacy both oral iron and injectable group was statistically significant. The value of p is < 0.00001. The result is significant at p ≤ 0.05.
Conclusion: We can conclude from this study that injection FCM is a promising alternative for IDA as its compliance is better than others, it can be safely used for correction of anaemia without any side effects over the mother and fetus.

Keywords:
IDA, FCM, Iron sucrose, Anaemia in pregnancy. Injectable iron

How to cite : Maheshwari B, Mahtab V, Tyagi S, Tyagi P, Evaluation of efficacy, safety and cost effectiveness of oral iron and injectable iron sucrose and ferric carboxy maltose in pregnant women in 2nd and 3rd trimester in anaemia. Indian J Obstet Gynecol Res 2017;4(1):96-100

Copyright © 2017 by author(s) and Indian J Obstet Gynecol Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)